Comprehensive and unbiased multiparameter high-throughput screening by compaRe finds effective and subtle drug responses in AML models

  1. Morteza Chalabi Hajkarim
  2. Ella Karjalainen
  3. Mikhail Osipovitch
  4. Konstantinos Dimopoulos
  5. Sandra L Gordon
  6. Francesca Ambri
  7. Kasper Dindler Rasmussen
  8. Kirsten Grønbæk
  9. Kristian Helin
  10. Krister Wennerberg  Is a corresponding author
  11. Kyoung-Jae Won  Is a corresponding author
  1. University of Copenhagen, Denmark
  2. University of Helsinki, Finland
  3. Rigshospitalet, Denmark
  4. University of Dundee, United Kingdom
  5. Memorial Sloan Kettering Cancer Center, United States

Abstract

Large-scale multiparameter screening has become increasingly feasible and straightforward to perform thanks to developments in technologies such as high-content microscopy and high-throughput flow cytometry. The automated toolkits for analyzing similarities and differences between large numbers of tested conditions have not kept pace with these technological developments. Thus, effective analysis of multiparameter screening datasets becomes a bottleneck and a limiting factor in unbiased interpretation of results. Here we introduce compaRe, a toolkit for large-scale multiparameter data analysis, which integrates quality control, data bias correction, and data visualization methods with a mass-aware gridding algorithm-based similarity analysis providing a much faster and more robust analyses than existing methods. Using mass and flow cytometry data from acute myeloid leukemia and myelodysplastic syndrome patients, we show that compaRe can reveal interpatient heterogeneity and recognizable phenotypic profiles. By applying compaRe to high-throughput flow cytometry drug response data in AML models, we robustly identified multiple types of both deep and subtle phenotypic response patterns, highlighting how this analysis could be used for therapeutic discoveries. In conclusion, compaRe is a toolkit that uniquely allows for automated, rapid, and precise comparisons of large-scale multiparameter datasets, including high-throughput screens.

Data availability

Mass cytometry datasets were downloaded from Cytobank Community with the experiment ID 44185. AML mouse and human high-throughput flow cytometry data have been deposited in FLOWRepository with the repository IDs FR-FCM-Z357 and FR-FCM-Z3DP respectively. Flow cytometry data of AML and MDS patients have been deposited in FLOWRepository with the repository ID FR-FCM-Z3ET. Acquisition, installation and more technical details are available in compaRe's online tutorial on (https://github.com/morchalabi/COMPARE-suite). Similarity measurement and clustering modules as stand-alone tools have been merged into a separate R package and are available for download at (https://github.com/morchalabi/compaRe).

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Morteza Chalabi Hajkarim

    Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2039-2676
  2. Ella Karjalainen

    Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland
    Competing interests
    The authors declare that no competing interests exist.
  3. Mikhail Osipovitch

    Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  4. Konstantinos Dimopoulos

    Rigshospitalet, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  5. Sandra L Gordon

    Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0270-8291
  6. Francesca Ambri

    Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  7. Kasper Dindler Rasmussen

    School of Life Sciences, University of Dundee, Dundee, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Kirsten Grønbæk

    Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  9. Kristian Helin

    Cell Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Krister Wennerberg

    Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark
    For correspondence
    krister.wennerberg@bric.ku.dk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1352-4220
  11. Kyoung-Jae Won

    Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark
    For correspondence
    kyoung.won@bric.ku.dk
    Competing interests
    The authors declare that no competing interests exist.

Funding

Novo Nordisk Foundation center for Stem Cell Biology (NNF17CC0027852)

  • Kirsten Grønbæk
  • Kristian Helin
  • Krister Wennerberg
  • Kyoung-Jae Won

Kræftens Bekæmpelse (R223‐A13071)

  • Kirsten Grønbæk
  • Kristian Helin
  • Krister Wennerberg
  • Kyoung-Jae Won

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: The informed consent, and consent to publish of patient samples in this study has been approved by the Danish National Science Ethics Committee/National Videnskabsetisk Komite: Målrettet behandling af patienter med blodsygdomme, license no. 1705391.

Copyright

© 2022, Chalabi Hajkarim et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,387
    views
  • 219
    downloads
  • 3
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Morteza Chalabi Hajkarim
  2. Ella Karjalainen
  3. Mikhail Osipovitch
  4. Konstantinos Dimopoulos
  5. Sandra L Gordon
  6. Francesca Ambri
  7. Kasper Dindler Rasmussen
  8. Kirsten Grønbæk
  9. Kristian Helin
  10. Krister Wennerberg
  11. Kyoung-Jae Won
(2022)
Comprehensive and unbiased multiparameter high-throughput screening by compaRe finds effective and subtle drug responses in AML models
eLife 11:e73760.
https://doi.org/10.7554/eLife.73760

Share this article

https://doi.org/10.7554/eLife.73760

Further reading

    1. Computational and Systems Biology
    2. Genetics and Genomics
    Fangluo Chen, Dylan C Sarver ... G William Wong
    Research Article

    Obesity is a major risk factor for type 2 diabetes, dyslipidemia, cardiovascular disease, and hypertension. Intriguingly, there is a subset of metabolically healthy obese (MHO) individuals who are seemingly able to maintain a healthy metabolic profile free of metabolic syndrome. The molecular underpinnings of MHO, however, are not well understood. Here, we report that CTRP10/C1QL2-deficient mice represent a unique female model of MHO. CTRP10 modulates weight gain in a striking and sexually dimorphic manner. Female, but not male, mice lacking CTRP10 develop obesity with age on a low-fat diet while maintaining an otherwise healthy metabolic profile. When fed an obesogenic diet, female Ctrp10 knockout (KO) mice show rapid weight gain. Despite pronounced obesity, Ctrp10 KO female mice do not develop steatosis, dyslipidemia, glucose intolerance, insulin resistance, oxidative stress, or low-grade inflammation. Obesity is largely uncoupled from metabolic dysregulation in female KO mice. Multi-tissue transcriptomic analyses highlighted gene expression changes and pathways associated with insulin-sensitive obesity. Transcriptional correlation of the differentially expressed gene (DEG) orthologs in humans also shows sex differences in gene connectivity within and across metabolic tissues, underscoring the conserved sex-dependent function of CTRP10. Collectively, our findings suggest that CTRP10 negatively regulates body weight in females, and that loss of CTRP10 results in benign obesity with largely preserved insulin sensitivity and metabolic health. This female MHO mouse model is valuable for understanding sex-biased mechanisms that uncouple obesity from metabolic dysfunction.

    1. Computational and Systems Biology
    Huiyong Cheng, Dawson Miller ... Qiuying Chen
    Research Article

    Mass spectrometry imaging (MSI) is a powerful technology used to define the spatial distribution and relative abundance of metabolites across tissue cryosections. While software packages exist for pixel-by-pixel individual metabolite and limited target pairs of ratio imaging, the research community lacks an easy computing and application tool that images any metabolite abundance ratio pairs. Importantly, recognition of correlated metabolite pairs may contribute to the discovery of unanticipated molecules in shared metabolic pathways. Here, we describe the development and implementation of an untargeted R package workflow for pixel-by-pixel ratio imaging of all metabolites detected in an MSI experiment. Considering untargeted MSI studies of murine brain and embryogenesis, we demonstrate that ratio imaging minimizes systematic data variation introduced by sample handling, markedly enhances spatial image contrast, and reveals previously unrecognized metabotype-distinct tissue regions. Furthermore, ratio imaging facilitates identification of novel regional biomarkers and provides anatomical information regarding spatial distribution of metabolite-linked biochemical pathways. The algorithm described herein is applicable to any MSI dataset containing spatial information for metabolites, peptides or proteins, offering a potent hypothesis generation tool to enhance knowledge obtained from current spatial metabolite profiling technologies.